Chuanqing Wu

942 citations
27 papers · 567 indexed · h-index 16
Topics
Hedgehog Signaling Pathway Studies (8 papers)Epigenetics and DNA Methylation (8 papers)Cancer-related molecular mechanisms research (7 papers)
Partner nations
ChinaUnited States

In The Last Decade

Chuanqing Wu

26 papers receiving 564 citations

Peers

Chuanqing Wu
Comparison fields: 5 of 77
  • Molecular Biology 440
  • Cancer Research 194
  • Oncology 110
  • Genetics 97
  • Pulmonary and Respiratory Medicine 50
Replace Frauke Goeman with:
Frauke Goeman Italy
Petra Laspe Germany
Siyang Dong China
Huairui Yuan China
Miaofeng Zhang China
Rachel J. Suetani Australia
Shaheen S. Sikandar United States
Shao‐Lan Qin China
Jinhua Han China
Fang Cui China
Chuanqing Wu relative to Frauke Goeman Italy Frauke Goeman's profile →
Citations per field
00.5×1.5×2.1×
Frauke Goeman · 1×
Citations per year

Countries citing papers authored by Chuanqing Wu

Since Specialization
Citations

This map shows the geographic impact of Chuanqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanqing Wu more than expected).

Fields of papers citing papers by Chuanqing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanqing Wu. The network helps show where Chuanqing Wu may publish in the future.

Co-authorship network of co-authors of Chuanqing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanqing Wu. A scholar is included among the top collaborators of Chuanqing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanqing Wu. Chuanqing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 7
5 24
6 11
7 36
8 2
9 6
10 43
11 18
12 23
13 24
14 64
15 7
16 43
17
Inhibition of SALL4 suppresses carcinogenesis of colorectal cancer via regulating Gli1 expression.
20
18 32
19 25
20 36

About Chuanqing Wu

Chuanqing Wu is a scholar working on Cancer Research, Developmental Biology and Molecular Biology, having authored 27 papers that have together received 567 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (8 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (194 citations), Molecular Biology (440 citations) and Oncology (110 citations). Chuanqing Wu has collaborated with scholars based in China and United States. Frequent co-authors include Kaixiong Tao, Tuo Ruan, Weizhen Liu, Xiaojie Zhu, Guobin Wang, Chengbing Wang, Xianxiong Ma, Weikang Zhang, Xiaoming Shuai and Ting Cao. Their work appears in journals such as PLoS ONE, Cancer Research and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026